IntelyCare is the second-largest healthcare per diem staffing company with a strong nationwide presence and a 97 percent recovery rate among active nurses returning to the same facilities. In January 2026, the company announced the acquisition of CareRev, bringing together two experienced platforms to serve both post-acute and acute care segments.
Cyborg Score Rationale
IntelyCare became a unicorn in 2022, reaching the milestone in 6 years. The company generated $77.7 million in annual revenue in 2026, supported by $174M in funding from investors like Endeavour Vision, Revelation Partners and Janus Henderson Investors, with a current valuation of $1.1B.
Top Insights
Market leadership as second-largest healthcare per diem staffing company with 97% nurse retention rate, indicating sustainable recurring revenue opportunities.
January 2026 acquisition of CareRev creates integrated platform for health systems to manage both permanent and contingent labor across acute and post-acute care.
Operates the largest nationwide nurse-only job board and is the 2nd largest healthcare per diem staffing company.
As of February 2026, IntelyCare has approximately 2,100 employees across 4 continents including North America, Asia, and Europe.
Named Competitors
Nomad Health — Healthcare staffing for travel nurses and allied health professionals
ShiftMed — On-demand nurse staffing platform
Incredible Health — Healthcare career marketplace connecting professionals with employers
CareRev — On-demand workforce platform for acute care (acquired January 2026)
Recent Developments
(January 2026) Acquired CareRev, an on-demand workforce platform purpose-built for acute care.
(June 2024) Announced integration partnership with Trio VMS, the leading healthcare vendor management system.
(April 2022) Closed $115M Series C funding round with 6 investors.
Open the full interactive IntelyCare, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.